[1] 何庆红,赵绍阳,臧文斌.国家基本药物制度实施减轻了患者医疗负担吗?[J].经济评论, 2019,(5):92-109 [2] 李钊,赵珂,周绿林,等.国家集采常态化视域下药品集团采购模式对比及发展对策研究[J].中国卫生政策研究, 2021,14(11):61-66 [3] 国家医疗保障局.深化药品和高值医用耗材集中带量采购改革进展国务院政策例行吹风会[EB/OL]. http://www.nhsa.gov.cn/art/2022/2/11/art_14_7835.html, 2022-02-11 [4] 岳晓菲,薛镭,陶元,等.社会办医综合监管问题及对策探讨[J].中华医院管理杂志, 2020,36(8):620-624 [5] 朱恒鹏.管制的内生性及其后果:以医药价格管制为例[J].世界经济, 2011,34(7):64-90 [6] 于长永."4+7"药品带量采购的实践效果与制度隐忧[J].西南民族大学学报(人文社科版), 2020,41(4):34-39 [7] 于良春,甘超.垄断与竞争:中国医疗行业市场效率分析[J].经济与管理研究, 2020,41(6):47-58 [8] 杨涛,魏云捷.医药政策变动对二级市场影响的实证研究:基于集合经验模态分解[J].管理评论, 2021,33(3):66-74 [9] Burns L. R., Lee J. A. Hospital Purchasing Alliances:Utilization, Services, and Performance[J]. Health Care Management Review, 2008,33(3):203-215 [10] Cowie M. Group Purchasing Organizations and Antitrust Law:Recent Developments[R]. American Health Lawyers Association, 2011 [11] Saha R. L., Seidmann A., Tilson V. The Impact of Custom Contracting and the Infomediary Role of Healthcare GPOs[J]. Production and Operations Management, 2019,28(3):650-667 [12] Huang Z., Lan Y., Zha X. Research on Government Subsidy Strategies for New Drug R&D Considering Spillover Effects[J]. PLoS One, 2022,17(2):e0262655 [13] Kouvelis P., Xiao Y., Yang N. PBM Competition in Pharmaceutical Supply Chain:Formulary Design and Drug Pricing[J]. Manufacturing&Service Operations Management, 2015,17(4):511-526 [14] 杨丹丹,侯文华.考虑渠道竞争和医保政策的医药供应链双渠道定价策略[J].管理学报, 2019,16(6):932-938 [15] Zhang H., Zaric G. S., Huang T. Optimal Design of a Pharmaceutical Price-volume Agreement under Asymmetric Information about Expected Market Size[J]. Production and Operations Management, 2011,20(3):334-346 [16] Hosseini-Motlagh S. M., Jazinaninejad M., Nami N. Coordinating a Socially Concerned Reverse Supply Chain for Pharmaceutical Waste Management Considering Government Role[J]. Environment Development and Sustainability, 2022,24(2):1852-1877 [17] Gao L. Y., Wang X. L. Healthcare Supply Chain Network Coordination through Medical Insurance Strategies with Reference Price Effect[J]. International Journal of Environmental Research and Public Health, 2019,16(18):3479 [18] Kaya O., Teymourifar A., Ozturk G. Public and Private Healthcare Coordination:An Analysis of Contract Mechanisms Based on Subsidy Payments[J]. Computers&Industrial Engineering, 2020,146(1):106526 [19] Ran Y., Hu Y. Y., Chen S. M., et al. The Impact of Two-Invoice System on Pharmaceutical Manufacturers'Selling Expenses in China:A Difference-in-Differences Approach[J]. International Journal of Environmental Research and Public Health, 2022,19(7):4400 [20] 李先国.药品供应链的整合问题研究[J].管理世界, 2010,(5):176-177 [21] 杨张博,高山行,郝志阳.尺蠖效应:基于扎根理论的医药企业战略再导向研究[J].管理评论, 2016,28(11):203-216 [22] Hezarkhani B., Sosic'G. Who's Afraid of Strategic Behavior?Mechanisms for Group Purchasing[J]. Production and Operations Management, 2019,28(4):933-954 [23] Hu Q., Schwarz L. B. Controversial Role of GPOs in Healthcare-Product Supply Chains[J]. Production and Operations Management, 2011,20(1):1-15 [24] 张新鑫,侯文华,申成霖.集中采购规制下制药企业创新激励与市场绩效研究[J].系统工程理论与实践, 2017,37(6):1557-1567 [25] Hu Q., Schwarz L. B., Uhan N. A. The Impact of Group Purchasing Organizations on Healthcare-Product Supply Chains[J]. Manufacturing&Service Operations Management, 2012,14(1):7-23 [26] Yan Y., Zhao R., Lan Y. Asymmetric Retailers with Different Moving Sequences:Group Buying vs. Individual Purchasing[J]. European Journal of Operational Research, 2017,261(3):903-917 [27] Ahmadi A., Heydari M., Pishvaee M. S., et al. Strategic Decisions to Join Group Purchasing Organizations[J]. Computers&Industrial Engineering, 2020,149(1):106869 [28] 吴璐,郭强,聂佳佳,等.预测信息分享对药品双渠道供应链集团采购策略的影响[J/OL].中国管理科学:1-12[2023-01-05]. DOI:10.16381/j.cnki.issn1003-207x.2020.1590 [29] 刘昉,崔啸天,傅鸿鹏.我国各省份新一轮集中招标采购政策对比分析[J].中国卫生经济, 2018,37(4):75-79 [30] 张新鑫,侯文华,申成霖,等.集中采购参与意愿、制药企业议价能力与药品市场绩效[J].中国管理科学, 2017,25(7):113-122 [31] 王帆,侯艳红.医疗供应链中GPO作用分析[J].中国医药工业杂志, 2016,47(5):660-665 [32] 丛鹂萱,陈珉惺,邹璇,等.美国集团采购组织核心要素介绍及与深圳模式对比分析[J].中国卫生经济, 2019,38(12):113-116 [33] Dobson A., Heath S., Luu P. H., et al. A 2018 Update of Cost Savings and Marketplace Analysis of the Health Care Group Purchasing Industry[R]. Washington, D.C.:Dobson DaVanzo&Associates, LLC, 2019 [34] Yang Y. C., Cheng H. K., Ding C., et al. To Join or Not to Join Group Purchasing Organization:A Vendor's Decision[J]. European Journal of Operational Research, 2016,258(2):581-589 [35] 李海,崔南方,徐贤浩.基于讨价还价能力的双渠道供应链批发价谈判模式[J].管理工程学报, 2015,29(4):124-132 |